Correlation Between GlaxoSmithKline PLC and AdvisorShares Gerber

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and AdvisorShares Gerber at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and AdvisorShares Gerber into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and AdvisorShares Gerber Kawasaki, you can compare the effects of market volatilities on GlaxoSmithKline PLC and AdvisorShares Gerber and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of AdvisorShares Gerber. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and AdvisorShares Gerber.

Diversification Opportunities for GlaxoSmithKline PLC and AdvisorShares Gerber

-0.85
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and AdvisorShares is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and AdvisorShares Gerber Kawasaki in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AdvisorShares Gerber and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with AdvisorShares Gerber. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AdvisorShares Gerber has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and AdvisorShares Gerber go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and AdvisorShares Gerber

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the AdvisorShares Gerber. In addition to that, GlaxoSmithKline PLC is 1.24 times more volatile than AdvisorShares Gerber Kawasaki. It trades about -0.23 of its total potential returns per unit of risk. AdvisorShares Gerber Kawasaki is currently generating about 0.13 per unit of volatility. If you would invest  2,172  in AdvisorShares Gerber Kawasaki on August 31, 2024 and sell it today you would earn a total of  59.00  from holding AdvisorShares Gerber Kawasaki or generate 2.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  AdvisorShares Gerber Kawasaki

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
AdvisorShares Gerber 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AdvisorShares Gerber Kawasaki are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile forward-looking signals, AdvisorShares Gerber may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and AdvisorShares Gerber Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and AdvisorShares Gerber

The main advantage of trading using opposite GlaxoSmithKline PLC and AdvisorShares Gerber positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, AdvisorShares Gerber can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AdvisorShares Gerber will offset losses from the drop in AdvisorShares Gerber's long position.
The idea behind GlaxoSmithKline PLC ADR and AdvisorShares Gerber Kawasaki pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets